Literature DB >> 6547725

Assay for catechol-O-methyltransferase in erythrocytes using a new fluorogenic substrate, 2-(3,4-dihydroxyphenyl)naphtho[1,2-d]thiazole.

H Nohta, S Noma, Y Ohkura, B T Yoo.   

Abstract

A highly sensitive method for the assay of catechol-O-methyltransferase in erythrocytes is described, which employs high-performance liquid chromatography with fluorescence detection. A newly synthesized catechol compound, 2-(3,4-dihydroxyphenyl)naphtho [1,2-d]thiazole is used as a highly fluorogenic substrate for catechol-O-methyltransferase; the m- and p-methylated products formed enzymatically from the substrate under the optimum conditions, after extraction with n-hexane--chloroform, are separated by normal-phase chromatography on LiChrosorb Si 100. The limits of detection for m- and p-methylated products are 3 pmol per assay tube (60 fmol per injection volume of 20 microliter) in each case. The ratio of m- and p-methylated products was 0.54. This method requires as little as 50 microliter of human erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6547725     DOI: 10.1016/s0021-9673(01)87536-1

Source DB:  PubMed          Journal:  J Chromatogr


  3 in total

Review 1.  Optical substrates for drug-metabolizing enzymes: Recent advances and future perspectives.

Authors:  Qiang Jin; JingJing Wu; Yue Wu; Hongxin Li; Moshe Finel; Dandan Wang; Guangbo Ge
Journal:  Acta Pharm Sin B       Date:  2022-01-21       Impact factor: 14.903

2.  Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose levodopa.

Authors:  J Dingemanse; K Jorga; G Zürcher; M Schmitt; G Sedek; M Da Prada; P Van Brummelen
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

Review 3.  Analytical methodologies for sensing catechol-O-methyltransferase activity and their applications.

Authors:  Fang-Yuan Wang; Ping Wang; Dong-Fang Zhao; Frank J Gonzalez; Yu-Fan Fan; Yang-Liu Xia; Guang-Bo Ge; Ling Yang
Journal:  J Pharm Anal       Date:  2020-04-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.